BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 18221619)

  • 1. Is there a cardiomyopathy of obesity?
    Owan T; Litwin SE
    Curr Heart Fail Rep; 2007 Dec; 4(4):221-8. PubMed ID: 18221619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new porcine model of hypertensive cardiomyopathy: a helpful tool to explore the HFpEF mystique.
    Hu K; Ertl G
    Am J Physiol Heart Circ Physiol; 2015 Nov; 309(9):H1390-1. PubMed ID: 26386114
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiac Effects of Obesity: PATHOPHYSIOLOGIC, CLINICAL, AND PROGNOSTIC CONSEQUENCES-A REVIEW.
    Alpert MA; Lavie CJ; Agrawal H; Kumar A; Kumar SA
    J Cardiopulm Rehabil Prev; 2016; 36(1):1-11. PubMed ID: 26629864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of obesity cardiomyopathy.
    Alpert MA
    Am J Med Sci; 2001 Apr; 321(4):237-41. PubMed ID: 11307865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of bariatric surgery on echocardiographic indices: a review of the literature.
    Grapsa J; Tan TC; Paschou SA; Kalogeropoulos AS; Shimony A; Kaier T; Demir OM; Mikhail S; Hakky S; Purkayastha S; Ahmed AR; Cousins J; Nihoyannopoulos P
    Eur J Clin Invest; 2013 Nov; 43(11):1224-30. PubMed ID: 24117129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obesity cardiomyopathy: pathophysiology and evolution of the clinical syndrome.
    Alpert MA
    Am J Med Sci; 2001 Apr; 321(4):225-36. PubMed ID: 11307864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hypertension in the pathogenesis of heart failure. A clinical mechanistic overview.
    Vasan RS; Levy D
    Arch Intern Med; 1996 Sep; 156(16):1789-96. PubMed ID: 8790072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic Relation of Changes in Weight and Indices of Fat Distribution With Cardiac Structure and Function: The Dallas Heart Study.
    Wilner B; Garg S; Ayers CR; Maroules CD; McColl R; Matulevicius SA; de Lemos JA; Drazner MH; Peshock R; Neeland IJ
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28724650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and heart failure.
    De Pergola G; Nardecchia A; Giagulli VA; Triggiani V; Guastamacchia E; Minischetti MC; Silvestris F
    Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):51-7. PubMed ID: 23369137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management.
    Alpert MA; Lavie CJ; Agrawal H; Aggarwal KB; Kumar SA
    Transl Res; 2014 Oct; 164(4):345-56. PubMed ID: 24814682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Obesity on Cardiovascular Hemodynamics, Cardiac Morphology, and Ventricular Function.
    Alpert MA; Omran J; Bostick BP
    Curr Obes Rep; 2016 Dec; 5(4):424-434. PubMed ID: 27744513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic Resonance Characterization of Cardiac Adaptation and Myocardial Fibrosis in Pulmonary Hypertension Secondary to Systemic-To-Pulmonary Shunt.
    Pereda D; García-Lunar I; Sierra F; Sánchez-Quintana D; Santiago E; Ballesteros C; Encalada JF; Sánchez-González J; Fuster V; Ibáñez B; García-Álvarez A
    Circ Cardiovasc Imaging; 2016 Sep; 9(9):. PubMed ID: 27601365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiomyopathy With Restrictive Physiology in Sickle Cell Disease.
    Niss O; Quinn CT; Lane A; Daily J; Khoury PR; Bakeer N; Kimball TR; Towbin JA; Malik P; Taylor MD
    JACC Cardiovasc Imaging; 2016 Mar; 9(3):243-52. PubMed ID: 26897687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
    Bobbo M; Pinamonti B; Merlo M; Stolfo D; Iorio A; Ramani F; Barbati G; Carriere C; Massa L; Poli S; Scapol S; Gigli M; Di Lenarda A; Sinagra G
    Am J Cardiol; 2017 Feb; 119(3):483-489. PubMed ID: 27988039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is uremic cardiomyopathy a direct consequence of chronic kidney disease?
    Chinnappa S; Hothi SS; Tan LB
    Expert Rev Cardiovasc Ther; 2014 Feb; 12(2):127-30. PubMed ID: 24404903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Obesity and the prognosis of heart failure: the obesity paradox, myth or reality?].
    Bounhoure JP; Galinier M; Roncalli J; Massabuau P
    Bull Acad Natl Med; 2014 Jan; 198(1):61-9; discussion 69-70. PubMed ID: 26259287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Obesity and cardiac failure].
    Galinier M; Pathak A; Roncalli J; Massabuau P
    Arch Mal Coeur Vaiss; 2005 Jan; 98(1):39-45. PubMed ID: 15724418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension and cardiomyopathy in obesity. Treat the heart simultaneously].
    Wirth A
    MMW Fortschr Med; 2001 Oct; 143(42):39-42. PubMed ID: 11697285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure.
    daSilva-deAbreu A; Alhafez BA; Lavie CJ; Milani RV; Ventura HO
    Curr Opin Cardiol; 2021 Jul; 36(4):453-460. PubMed ID: 33929365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Congestive heart failure due to hypertensive ventricular diastolic dysfunction.
    Iriarte MM; Perez Olea J; Sagastagoitia D; Molinero E; Murga N
    Am J Cardiol; 1995 Nov; 76(13):43D-47D. PubMed ID: 7495217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.